Undifferentiated spondyloarthritis vs ankylosing spondylitis and psoriatic arthritis: A real-life prospective cohort study of clinical presentation and response to treatment

Rheumatology (United Kingdom)

Volumn 52, Issue 10, 2013, Pages 1873-1878

  Paramarta, Jacqueline E ^a   De Rycke, Leen ^a   Ambarus, Carmen A ^a   Tak, Paul P ^a,b   Baeten, Dominique ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Ankylosing spondylitis; Anti TNF treatment; Psoriatic arthritis; Spondyloarthritis; Undifferentiatied spondyloarthritis

Indexed keywords

CORTICOSTEROID; DISEASE MODIFYING ANTIRHEUMATIC DRUG; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR ANTIBODY;

ADULT; ANKYLOSING SPONDYLITIS; ANKYLOSING SPONDYLITIS DISEASE ACTIVITY SCORE; ARTICLE; BACKACHE; BATH ANKYLOSING SPONDYLITIS DISEASE ACTIVITY INDEX; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE CLASSIFICATION; DISEASE SEVERITY; EARLY DIAGNOSIS; FEMALE; FOLLOW UP; HUMAN; INFLAMMATORY PAIN; MAJOR CLINICAL STUDY; MALE; OUTPATIENT DEPARTMENT; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSORIATIC ARTHRITIS; SACROILIITIS; SPINE RADIOGRAPHY; SPONDYLARTHRITIS; TREATMENT RESPONSE; VISUAL ANALOG SCALE;

EID: 84887325657     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ket239     Document Type: Article

References (20)

1. Dougados M, van der Linden S, Juhlin R et al. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 1991;34:1218-27.
2. Baeten D, Breban M, Lories R et al. Are spondylarthritides related but distinct conditions or a single disease with a heterogeneous phenotype? Arthritis Rheum 2013;65:12-20.
3. van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 1984;27:361-8.
4. Rojas-Vargas M, Munoz-Gomariz E, Escudero A et al. First signs and symptoms of spondyloarthritis-data from an inception cohort with a disease course of two years or less (REGISPONSER-Early). Rheumatology 2009;48:404-9.
5. Rudwaleit M, Haibel H, Baraliakos X et al. The early disease stage in axial spondylarthritis: results from the German Spondyloarthritis Inception Cohort. Arthritis Rheum 2009;60:717-27.
6. Kiltz U, Baraliakos X, Karakostas P et al. Patients with non-radiographic axial spondyloarthritis differ from patients with ankylosing spondylitis in several aspects. Arthritis Care Res 2012;64:1415-22.
7. Rudwaleit M, van der Heijde D, Landewe R et al. The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis 2011;70:25-31.
8. Van Den Bosch F, Kruithof E, Baeten D et al. Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor alpha (infliximab) versus placebo in active spondylarthropathy. Arthritis Rheum 2002;46:755-65.
9. Paramarta JE, De Rycke L, Heijda TF et al. Efficacy and safety of adalimumab for the treatment of peripheral arthritis in spondyloarthritis patients without ankylosing spondylitis or psoriatic arthritis. Ann Rheum Dis 2012; doi:10.1136/annrheumdis-2012-202245.
10. Sieper J, van der Heijde D, Dougados M et al. Efficacy and safety of adalimumab in patients with non-radiographic axial spondyloarthritis: results of a randomised placebo-controlled trial (ABILITY-1). Ann Rheum Dis 2013;72:815-22.
11. Mease P, Sieper J, Van Den Bosch F et al. Efficacy and safety of adalimumab in patients with peripheral spondyloarthritis: results from a phase 3 study [abstract]. Ann Rheum Dis 2012;71:250.
12. Taylor WJ, Helliwell PS. Development of diagnostic criteria for psoriatic arthritis: methods and process. Curr Rheumatol Rep 2004;6:299-305.
13. Garrett S, Jenkinson T, Kennedy LG et al. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 1994;21:2286-91.
14. Machado P, Landewe R, Lie E et al. Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-offvalues for disease activity states and improvement scores. Ann Rheum Dis 2011;70:47-53.
15. Munoz-Fernandez S, de Miguel E, Cobo-Ibanez T et al. Early spondyloarthritis: results from the pilot registry ESPIDEP. Clin Exp Rheumatol 2010;28:498-503.
16. Reveille JD, Witter JP, Weisman MH. Prevalence of axial spondylarthritis in the United States: estimates from a cross-sectional survey. Arthritis Care Res 2012;64:905-10.
17. Huerta-Sil G, Casasola-Vargas JC, Londono JD et al. Low grade radiographic sacroiliitis as prognostic factor in patients with undifferentiated spondyloarthritis fulfilling diagnostic criteria for ankylosing spondylitis throughout follow up. Ann Rheum Dis 2006;65:642-6.
18. Heuft-Dorenbosch L, Landewe R, Weijers R et al. Performance of various criteria sets in patients with inflammatory back pain of short duration; the Maastricht early spondyloarthritis clinic. Ann Rheum Dis 2007;66:92-8.
19. Sampaio-Barros PD, Bortoluzzo AB, Conde RA et al. Undifferentiated spondyloarthritis: a longterm followup. J Rheumatol 2010;37:1195-9.
20. Dougados M, d'Agostino MA, Benessiano J et al. The DESIR cohort: a 10-year follow-up of early inflammatory back pain in France: study design and baseline characteristics of the 708 recruited patients. Joint Bone Spine 2011;78:598-603.